treatments epilepsy neuropsychiatric disorders

Mindful Innovation

Bringing Hope to Patients

Developing new treatments to improve the lives of patients and families affected by epilepsy and neuropsychiatric disorders.
Our Pledge to Patients

 

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings.

Our Science & Pipeline
 
post partum depression indications

Postpartum Depression

Striving to Support Strong Mother-Baby Bonds

Developing therapies with the potential to address postpartum depression more quickly and in an outpatient setting.

Learn More
 

Orphan Epilepsies

Aspiring to Give Children Seizure-Free Days

Ganaxolone offers the potential to safely decrease seizure frequency in children with refractory epilepsy.

Learn More
 

WHY WE WORK

To make a difference in the lives of patients and their families.

  • ARTWORK BY AVA This artwork was mabe by young Ava.
  • KIERA
  • AMANDA
  • VIOLET
  • ARTWORK BY G
  • SLOAN
normal healthy girl father

FOLLOW US ON TWITTER

Cleveland movers
Cleveland movers